ALIVUS - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 05 Nov 25, 7:43 am

Technical Rating: 3.4

Technical Analysis Report

• Trend Status: Reversing downward
• Moving Averages: Price (₹916) is below both 50 DMA (₹943) and 200 DMA (₹989), indicating bearish alignment
• RSI (38.5): Weak momentum, approaching oversold zone
• MACD (-10.6): Bearish crossover, confirming downward pressure
• Bollinger Bands: Price near lower band, suggesting potential short-term bounce
• Volume: Below average (31.7K vs 54.8K), showing low market participation
• Support Zones: ₹900, ₹875
• Resistance Zones: ₹945, ₹970
• Entry Zone: ₹900–₹915 (near support)
• Exit Zone: ₹945–₹970 (near resistance)

Positive

• Strong ROCE (24.9%) and ROE (18.7%) reflect solid operational efficiency
• Debt-to-equity ratio of 0.02 indicates excellent financial discipline
• EPS of ₹40.4 supports earnings visibility
• FII holding increased by 0.42%, showing foreign investor confidence

Limitation

• Price below both key moving averages confirms bearish trend
• MACD and RSI indicate weak momentum and downside pressure
• Volume significantly below average, suggesting low conviction
• PEG ratio of 4.82 implies premium valuation

Company Negative News

• Quarterly PAT declined from ₹142 Cr to ₹122 Cr
• DII holding dropped by 0.15%, reflecting cautious domestic sentiment

Company Positive News

• Quarterly profit variation of +9.02% shows year-over-year improvement
• Dividend yield of 0.55% offers modest shareholder return
• Stock has gained 20.7% from its 52-week low

Industry

• Pharmaceutical sector remains resilient with long-term demand and export opportunities
• Industry P/E of 33.1 suggests ALIVUS trades at a discount

Conclusion

• ALIVUS is in a bearish reversal phase with oversold signals emerging
• Entry near ₹900–₹915 could offer a tactical bounce opportunity
• Exit near ₹945–₹970 is ideal for short-term gains
• Investors should monitor RSI and MACD for confirmation of trend reversal